Stay updated on M2951 in SLE Phase II Clinical Trial
Sign up to get notified when there's something new on the M2951 in SLE Phase II Clinical Trial page.

Latest updates to the M2951 in SLE Phase II Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedNaples, Italy was added to the study locations and Napoli was updated to Naples in the Locations section.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedPage revision tag updated: v3.4.3 added, replacing v3.4.2. This appears to be a backend update with no change to the study details or user-facing content.SummaryDifference0.0%

- Check55 days agoChange DetectedThe revision indicator has been updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check62 days agoChange DetectedThe update shows a minor revision label changed from v3.4.0 to v3.4.1; no user-facing study content or functionality appears to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedMinor site revision update from v3.4.0 to v3.4.1; no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check71 days agoChange DetectedThese are minor UI and metadata updates: a 'Show glossary' option was added, capitalization tweaks were made to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the page now displays 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to M2951 in SLE Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M2951 in SLE Phase II Clinical Trial page.